(NEUE) NeueHealth - Ratings and Ratios

NeueHealth, Inc., a US-based healthcare company, is revolutionizing the healthcare landscape by providing a multifaceted array of services tailored to the needs of consumers, providers, and payors. The companys strategic segmentation into NeueCare and NeueSolutions enables it to effectively cater to diverse healthcare requirements.

The NeueCare segment is a critical component of NeueHealths operations, delivering comprehensive healthcare services to individuals enrolled in the ACA marketplace, Medicare, and Medicaid through its network of owned and affiliated clinics. Notably, the company operates risk-bearing clinics under prominent brand names such as Centrum Health and Premier Medical Associates, thereby ensuring a robust presence in the market. Furthermore, this segment offers an integrated suite of care solutions, encompassing embedded pharmacy, laboratory, radiology, and specialized services focused on population health, as well as chronic care management, transitions of care, and referral management services, thereby positioning NeueHealth as a holistic healthcare provider.

In contrast, the NeueSolutions segment is designed to empower providers and medical groups to thrive in performance-based arrangements, while also participating in initiatives aimed at enhancing access to healthcare services for Medicare beneficiaries. This dual focus underscores NeueHealths commitment to driving value-based care and improving healthcare outcomes. Having undergone a rebranding from Bright Health Group, Inc. to NeueHealth, Inc. in January 2024, the company has signaled its intent to forge a distinct identity in the healthcare landscape.

From a technical analysis perspective, NEUEs stock has demonstrated a relatively stable trend, with its last price of $6.84 being closely aligned with its 20-day Simple Moving Average (SMA) of $6.79. The stocks 50-day SMA and 200-day SMA stand at $6.47 and $6.02, respectively, indicating a gradual upward trajectory. Given the Average True Range (ATR) of 0.25, representing a 3.72% volatility, and considering the stocks 52-week high and low of $7.54 and $3.82, respectively, it is plausible that NEUE may continue to consolidate around its current price levels. However, a break above the 52-week high could signal a bullish trend.

Fundamentally, NeueHealths Market Cap stands at $61.07M USD, with a Return on Equity (RoE) of 21.99%, indicating a satisfactory level of profitability. Although the companys P/E ratio is not available, this metric is often less relevant for companies with complex business models or those operating in emerging industries. Considering the technical and fundamental data, a forecast for NEUE could be that it may experience a moderate increase in stock price, potentially reaching $7.20 in the short term, driven by its robust operational segments and favorable RoE. However, this projection is contingent upon the companys ability to continue delivering value-based care solutions and navigating the complexities of the US healthcare landscape.